ISLAMABAD: Special Assistant to Prime Minister on National Health Services Zafar Mirza will launch the first training course under the ‘We Care’ campaign at the Pakistan Institute of Medical Sciences (PIMS).
Taking to Twitter, Zafar Mirza wrote that it will be an online course that will be given to 100,000 Health Care Workers (HCW)s across the country.
Launching today at PIMS first training course on PPEs use under the auspices of “We Care! National Campaign for Protection and Support of Frontline Health Care Workers”. An online course which will be given to 100,000 HCWs across the country. All Hlth Ministers fully on board.
— Zafar Mirza (@zfrmrza) May 15, 2020
Earlier, Mirza assured that a local Pakistani company will manufacture Remdesivir, an international drug being used to treat coronavirus patients, in less than two months.
“American company Gilead has manufactured this drug and it has proven effective in treating coronavirus patients,” he said during a press conference. “It is said that the use of the drug has reduced the intensity of the virus by 30 percent.”
Dr. Mirza said that five companies in the world had been granted the license to manufacture the drug. “Among the five companies [granted the license to manufacture the drug] one of them is a Pakistani company,” he said, referring to it as a “breakthrough news”.
He said that the medicine will be available for COVID-19 patients in Pakistan after it is registered within six to eight weeks and manufactured in the country.
Read more: Will address genuine grievances of doctors: Zafar Mirza
ADVERTISEMENT
